U.S. AstraZeneca vaccine trial will clear confusion on how well it works: scientist
AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23… Read More
AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23… Read More
AstraZeneca expects 4 million doses to be available in Britain by the end of next… Read More
The vaccine developed by Oxford University was 90% effective in preventing COVID-19 when it was… Read More
The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in… Read More
The late-stage trials of the experimental vaccine, one of the most advanced in development, were… Read More
AstraZeneca should still know before the end of the year whether its experimental vaccine protects… Read More
Trial participants will receive either two doses of the experimental vaccine Read More
ChAdOx1 nCoV-19, now known as AZD1222, was developed by Oxford University’s Jenner Institute, working with… Read More
Results from the preliminary research involving 19 patients encouraged the British drugmaker to explore the… Read More
The company said it reached an agreement worth $750 million with the CEPI and Gavi… Read More
AstraZeneca said it had received marketing authorization from China’s National Medical Products Administration for its… Read More
AstraZeneca made strides on Tuesday towards its goal of adding heart failure to the conditions… Read More
MADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered impressive clinical results on… Read More
LONDON: Could Pfizer acquire GlaxoSmithKline as a "plan B" after failing to land AstraZeneca? It would… Read More